Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
48.8M
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
1.44M
-
Shares change
-
+1.44M
-
Total reported value, excl. options
-
$876K
-
Value change
-
+$876K
-
Number of buys
-
15
-
Price
-
$0.58
Significant Holders of Aspire Biopharma Holdings, Inc. - Common Stock (ASBP) as of Q1 2025
15 filings reported holding ASBP - Aspire Biopharma Holdings, Inc. - Common Stock as of Q1 2025.
Aspire Biopharma Holdings, Inc. - Common Stock (ASBP) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.44M shares
of 48.8M outstanding shares and own 2.94% of the company stock.
Largest 10 shareholders include TORONTO DOMINION BANK (517K shares), Crewe Advisors LLC (313K shares), Harraden Circle Investments, LLC (150K shares), Optivise Advisory Services LLC (106K shares), Procyon Advisors, LLC (98.5K shares), Periscope Capital Inc. (75K shares), Platform Technology Partners (37.6K shares), UBS Group AG (29.9K shares), TWO SIGMA SECURITIES, LLC (27.4K shares), and CITADEL ADVISORS LLC (26.9K shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.